These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12757623

  • 1. Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte.
    Nakao R, Hanada N, Asano T, Hara T, Abdus Salam M, Matin K, Shimazu Y, Nakasone T, Horibata S, Aoba T, Honda M, Amagasa T, Senpuku H.
    Immunology; 2003 Jun; 109(2):271-82. PubMed ID: 12757623
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S, Lapenta C, Santini SM, Spada M, Parlato S, Logozzi M, Rizza P, Belardelli F.
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y.
    J Infect Dis; 2008 Jan 01; 197(1):134-41. PubMed ID: 18171296
    [Abstract] [Full Text] [Related]

  • 5. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N.
    J Virol; 1997 Mar 01; 71(3):2417-24. PubMed ID: 9032379
    [Abstract] [Full Text] [Related]

  • 6. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P, Santini SM, Logozzi MA, Lapenta C, Sestili P, Gherardi G, Lande R, Spada M, Parlato S, Belardelli F, Fais S.
    J Virol; 1996 Nov 01; 70(11):7958-64. PubMed ID: 8892919
    [Abstract] [Full Text] [Related]

  • 7. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.
    Gorantla S, Santos K, Meyer V, Dewhurst S, Bowers WJ, Federoff HJ, Gendelman HE, Poluektova L.
    J Virol; 2005 Feb 01; 79(4):2124-32. PubMed ID: 15681415
    [Abstract] [Full Text] [Related]

  • 8. Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engraftment in NOD-scid mouse.
    Senpuku H, Asano T, Matin K, Salam MA, Tsuha Y, Horibata S, Shimazu Y, Soeno Y, Aoba T, Sata T, Hanada N, Honda M.
    Immunology; 2002 Oct 01; 107(2):232-42. PubMed ID: 12383203
    [Abstract] [Full Text] [Related]

  • 9. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
    Yoshida A, Tanaka R, Murakami T, Takahashi Y, Koyanagi Y, Nakamura M, Ito M, Yamamoto N, Tanaka Y.
    J Virol; 2003 Aug 01; 77(16):8719-28. PubMed ID: 12885891
    [Abstract] [Full Text] [Related]

  • 10. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 11. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y.
    J Exp Med; 2001 Mar 05; 193(5):651-60. PubMed ID: 11238596
    [Abstract] [Full Text] [Related]

  • 12. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB.
    AIDS Res Hum Retroviruses; 2016 Feb 05; 32(2):194-202. PubMed ID: 26564392
    [Abstract] [Full Text] [Related]

  • 13. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B, Torbett BE, Gulizia RJ, Reinhardt PP, Spector SA, Mosier DE.
    AIDS Res Hum Retroviruses; 1994 Feb 05; 10(2):131-41. PubMed ID: 8198867
    [Abstract] [Full Text] [Related]

  • 14. Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection.
    Kish TM, Budgeon LR, Welsh PA, Howett MK.
    Am J Pathol; 2001 Dec 05; 159(6):2331-45. PubMed ID: 11733382
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R.
    Retrovirology; 2006 Nov 01; 3():76. PubMed ID: 17078891
    [Abstract] [Full Text] [Related]

  • 16. Oral SIV, SHIV, and HIV type 1 infection.
    Ruprecht RM, Baba TW, Liska V, Ayehunie S, Andersen J, Montefiori DC, Trichel A, Murphey-Corb M, Martin L, Rizvi TA, Bernacky BJ, Buchl SJ, Keeling M.
    AIDS Res Hum Retroviruses; 1998 Apr 01; 14 Suppl 1():S97-103. PubMed ID: 9581893
    [Abstract] [Full Text] [Related]

  • 17. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S, Li H, Burnett JC, Takahashi M, Li S, Wu SX, Synold TW, Rossi JJ, Zhou J.
    J Virol; 2018 Apr 01; 92(7):. PubMed ID: 29343582
    [Abstract] [Full Text] [Related]

  • 18. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
    Di Fabio S, Giannini G, Lapenta C, Spada M, Binelli A, Germinario E, Sestili P, Belardelli F, Proietti E, Vella S.
    AIDS; 2001 Nov 23; 15(17):2231-8. PubMed ID: 11698695
    [Abstract] [Full Text] [Related]

  • 19. HIV-1/simian immunodeficiency virus infection of human and nonhuman primate lymphocytes results in the migration of CD2+ T cells into the intestine of engrafted SCID mice.
    Donze HH, Cummins JE, Schwiebert RS, Kantele A, Han Y, Fultz PN, Jackson S, Mestecky J.
    J Immunol; 1998 Mar 01; 160(5):2506-13. PubMed ID: 9498796
    [Abstract] [Full Text] [Related]

  • 20. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD.
    J Immunol; 1997 Apr 15; 158(8):3578-86. PubMed ID: 9103418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.